This Viewpoint advocates for more careful consideration of families and children in policymaking surrounding naloxone coprescribing or accessibility. Share: Previous Post Effects on Body Mass Index After the Philadelphia Beverage Tax Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Delivery Room Interventions for Hypothermia in Preterm Neonates Clinical Practice Guidelines Pediatric COVID-19 Disparities and Prioritizing Equity—Children Are Not Spared Clinical Practice Guidelines JAMA Pediatrics Peer Reviewers in 2021 Clinical Practice Guidelines Reevaluating the Association Between Autism and Lithium Exposure During Pregnancy Clinical Practice Guidelines Genetic Testing in Newborns Moves From Rare to Routine Application Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.